LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 202 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,992,083 | -1.7% | 40,931 | -4.0% | 0.15% | -7.8% |
| Q4 2023 | $3,043,842 | +49.7% | 42,619 | +25.6% | 0.17% | +31.7% |
| Q3 2023 | $2,033,441 | -37.7% | 33,936 | -25.1% | 0.13% | -35.1% |
| Q2 2023 | $3,265,830 | +59.0% | 45,296 | -18.8% | 0.19% | +48.1% |
| Q1 2023 | $2,053,788 | +147124.9% | 55,784 | +167.2% | 0.13% | +33.7% |
| Q4 2022 | $1,395 | -99.9% | 20,877 | -26.3% | 0.10% | -44.9% |
| Q3 2022 | $2,439,000 | -34.6% | 28,319 | -32.3% | 0.18% | -24.9% |
| Q2 2022 | $3,732,000 | -22.0% | 41,829 | -1.7% | 0.24% | -5.2% |
| Q1 2022 | $4,787,000 | -23.4% | 42,551 | +5.2% | 0.25% | -17.2% |
| Q4 2021 | $6,250,000 | -9.0% | 40,463 | -17.9% | 0.30% | -12.2% |
| Q3 2021 | $6,868,000 | +9.9% | 49,297 | +3.5% | 0.34% | +9.9% |
| Q2 2021 | $6,248,000 | -12.6% | 47,622 | +1.6% | 0.31% | -16.3% |
| Q1 2021 | $7,148,000 | +22.2% | 46,886 | -20.3% | 0.37% | +29.0% |
| Q4 2020 | $5,850,000 | -39.8% | 58,825 | -42.3% | 0.29% | -41.3% |
| Q3 2020 | $9,710,000 | -16.4% | 101,868 | -1.9% | 0.49% | -20.2% |
| Q2 2020 | $11,615,000 | +72.9% | 103,847 | +12.4% | 0.62% | +46.0% |
| Q1 2020 | $6,716,000 | -31.2% | 92,351 | -1.3% | 0.42% | -12.0% |
| Q4 2019 | $9,761,000 | -3.7% | 93,592 | -8.1% | 0.48% | -8.5% |
| Q3 2019 | $10,139,000 | -26.9% | 101,857 | -16.2% | 0.53% | -23.4% |
| Q2 2019 | $13,868,000 | +9.2% | 121,491 | +20.3% | 0.69% | -26.5% |
| Q1 2019 | $12,698,000 | +13.5% | 101,008 | +22.5% | 0.94% | +1.3% |
| Q4 2018 | $11,190,000 | -34.9% | 82,460 | +31.6% | 0.92% | -21.0% |
| Q3 2018 | $17,194,000 | -6.4% | 62,640 | -29.4% | 1.17% | -11.0% |
| Q2 2018 | $18,374,000 | +4.3% | 88,692 | -16.8% | 1.32% | +4.5% |
| Q1 2018 | $17,616,000 | +5.5% | 106,659 | -12.5% | 1.26% | +9.1% |
| Q4 2017 | $16,701,000 | -12.9% | 121,964 | -13.4% | 1.15% | -15.0% |
| Q3 2017 | $19,164,000 | +14.4% | 140,758 | +2.0% | 1.36% | +13.6% |
| Q2 2017 | $16,757,000 | +37.9% | 138,032 | +20.2% | 1.20% | +30.6% |
| Q1 2017 | $12,154,000 | -17.3% | 114,835 | -20.6% | 0.92% | -15.7% |
| Q4 2016 | $14,698,000 | -5.0% | 144,649 | -4.5% | 1.09% | +1.9% |
| Q3 2016 | $15,465,000 | -5.7% | 151,532 | +10.2% | 1.07% | -6.7% |
| Q2 2016 | $16,396,000 | -14.5% | 137,469 | -23.2% | 1.14% | -13.2% |
| Q1 2016 | $19,166,000 | +10.4% | 178,974 | +11.8% | 1.32% | +9.1% |
| Q4 2015 | $17,355,000 | +36.0% | 160,068 | +7.4% | 1.20% | +23.6% |
| Q3 2015 | $12,764,000 | +32.6% | 149,029 | +56.2% | 0.98% | +36.0% |
| Q2 2015 | $9,624,000 | – | 95,386 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |